Shares of Augmedix, Inc. (OTCMKTS:AUGX – Get Rating) have received an average rating of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued ratings on the stock in […]